{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:15:49Z","timestamp":1789820149589,"version":"4.0.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.1093\/jac\/dki239","type":"journal-article","created":{"date-parts":[[2005,7,9]],"date-time":"2005-07-09T00:14:01Z","timestamp":1120868041000},"page":"451-454","source":"Crossref","is-referenced-by-count":177,"title":["CTX-M: changing the face of ESBLs in the UK"],"prefix":"10.1093","volume":"56","author":[{"given":"D. M.","family":"Livermore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"Hawkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,7,8]]},"reference":[{"key":"key\n\t\t\t\t20171012171720_B1","doi-asserted-by":"crossref","unstructured":"Bradford PA. Extended-spectrum \u03b2-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev2001; 14: 933\u201351.","DOI":"10.1128\/CMR.14.4.933-951.2001"},{"key":"key\n\t\t\t\t20171012171720_B2","doi-asserted-by":"crossref","unstructured":"Bonnet R. Growing group of extended-spectrum \u03b2-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother2004; 48: 1\u201314.","DOI":"10.1128\/AAC.48.1.1-14.2004"},{"key":"key\n\t\t\t\t20171012171720_B3","doi-asserted-by":"crossref","unstructured":"Kliebe C, Nies BA, Meyer JF et al. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother1985; 28: 302\u20137.","DOI":"10.1128\/AAC.28.2.302"},{"key":"key\n\t\t\t\t20171012171720_B4","doi-asserted-by":"crossref","unstructured":"Sirot D. Extended-spectrum plasmid-mediated \u03b2-lactamases. J Antimicrob Chemother1995; 36 Suppl A: 19\u201334.","DOI":"10.1093\/jac\/36.suppl_A.19"},{"key":"key\n\t\t\t\t20171012171720_B5","doi-asserted-by":"crossref","unstructured":"Philippon A, Labia R, Jacoby G. Extended-spectrum \u03b2-lactamases. Antimicrob Agents Chemother1989; 33: 1131\u20136.","DOI":"10.1128\/AAC.33.8.1131"},{"key":"key\n\t\t\t\t20171012171720_B6","doi-asserted-by":"crossref","unstructured":"Nordmann P, Ronco E, Naas T et al. Characterization of a novel extended-spectrum \u03b2-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother1993; 37: 962\u20139.","DOI":"10.1128\/AAC.37.5.962"},{"key":"key\n\t\t\t\t20171012171720_B7","doi-asserted-by":"crossref","unstructured":"Danel F, Hall LM, Duke B et al. OXA-17, a further extended-spectrum variant of OXA-10 \u03b2-lactamase, isolated from Pseudomonas aeruginosa. Antimicrob Agents Chemother1999; 43: 1362\u20136.","DOI":"10.1128\/AAC.43.6.1362"},{"key":"key\n\t\t\t\t20171012171720_B8","doi-asserted-by":"crossref","unstructured":"Danel F, Hall LM, Gur D et al. OXA-15, an extended-spectrum variant of OXA-2 \u03b2-lactamase, isolated from a Pseudomonas aeruginosa strain. Antimicrob Agents Chemother1997; 41: 785\u201390.","DOI":"10.1128\/AAC.41.4.785"},{"key":"key\n\t\t\t\t20171012171720_B9","doi-asserted-by":"crossref","unstructured":"Radice M, Power P, Di Conza J et al. Early dissemination of CTX-M-derived enzymes in South America. Antimicrob Agents Chemother2002; 46: 602\u20134.","DOI":"10.1128\/AAC.46.2.602-604.2002"},{"key":"key\n\t\t\t\t20171012171720_B10","doi-asserted-by":"crossref","unstructured":"Miro E, Navarro F, Mirelis B et al. Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant \u03b2-lactamases at a University Hospital in Barcelona, Spain, over a 3-year period. Antimicrob Agents Chemother2002; 46: 3991\u20134.","DOI":"10.1128\/AAC.46.12.3991-3994.2002"},{"key":"key\n\t\t\t\t20171012171720_B11","doi-asserted-by":"crossref","unstructured":"Munday CJ, Xiong J, Li C et al. Dissemination of CTX-M type \u03b2-lactamases in Enterobacteriaceae isolates in the People's Republic of China. Int J Antimicrob Agents2004; 23: 175\u201380.","DOI":"10.1016\/j.ijantimicag.2003.07.004"},{"key":"key\n\t\t\t\t20171012171720_B12","doi-asserted-by":"crossref","unstructured":"Poirel L, Gniadkowski M, Nordmann P. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum \u03b2-lactamase CTX-M-15 and of its structurally related \u03b2-lactamase CTX-M-3. J Antimicrob Chemother2002; 50: 1031\u20134.","DOI":"10.1093\/jac\/dkf240"},{"key":"key\n\t\t\t\t20171012171720_B13","doi-asserted-by":"crossref","unstructured":"Hibbert-Rogers LC, Heritage J, Gascoyne-Binzi DM et al. Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward. J Antimicrob Chemother1995; 36: 65\u201382.","DOI":"10.1093\/jac\/36.1.65"},{"key":"key\n\t\t\t\t20171012171720_B14","doi-asserted-by":"crossref","unstructured":"Piddock LJ, Walters RN, Jin YF et al. Prevalence and mechanism of resistance to \u2018third-generation\u2019 cephalosporins in clinically relevant isolates of Enterobacteriaceae from 43 hospitals in the UK, 1990\u20131991. J Antimicrob Chemother1997; 39: 177\u201387.","DOI":"10.1093\/jac\/39.2.177"},{"key":"key\n\t\t\t\t20171012171720_B15","doi-asserted-by":"crossref","unstructured":"Verma A, Desai N, Shannon K et al. Intra- and inter-generic plasmid-mediated spread of cephalosporin and aminoglycoside resistance amongst Klebsiella aerogenes K41 and other enterobacteria. Int J Antimicrob Agents2001; 17: 123\u20139.","DOI":"10.1016\/S0924-8579(00)00324-1"},{"key":"key\n\t\t\t\t20171012171720_B16","doi-asserted-by":"crossref","unstructured":"Alobwede I, M'Zali FH, Livermore DM et al. CTX-M extended-spectrum \u03b2-lactamase arrives in the UK. J Antimicrob Chemother2003; 51: 470\u20131.","DOI":"10.1093\/jac\/dkg096"},{"key":"key\n\t\t\t\t20171012171720_B17","doi-asserted-by":"crossref","unstructured":"Brenwald NP, Jevons G, Andrews JM et al. An outbreak of a CTX-M-type \u03b2-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum \u03b2-lactamases. J Antimicrob Chemother2003; 51: 195\u20136.","DOI":"10.1093\/jac\/dkg051"},{"key":"key\n\t\t\t\t20171012171720_B18","doi-asserted-by":"crossref","unstructured":"Woodford N, Ward ME, Kaufmann ME et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum \u03b2-lactamases in the UK. J Antimicrob Chemother2004; 54: 735\u201343.","DOI":"10.1093\/jac\/dkh424"},{"key":"key\n\t\t\t\t20171012171720_B19","doi-asserted-by":"crossref","unstructured":"Munday CJ, Whitehead GM, Todd NJ et al. Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum \u03b2-lactamases in York, UK. J Antimicrob Chemother2004; 54: 628\u201333.","DOI":"10.1093\/jac\/dkh397"},{"key":"key\n\t\t\t\t20171012171720_B20","doi-asserted-by":"crossref","unstructured":"Valverde A, Coque TM, Sanchez-Moreno MP et al. Dramatic increase in prevalence of fecal carriage of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol2004; 42: 4769\u201375.","DOI":"10.1128\/JCM.42.10.4769-4775.2004"},{"key":"key\n\t\t\t\t20171012171720_B21","doi-asserted-by":"crossref","unstructured":"Reacher MH, Shah A, Livermore DM et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. Br Med J2000; 320: 213\u201316.","DOI":"10.1136\/bmj.320.7229.213"},{"key":"key\n\t\t\t\t20171012171720_B22","doi-asserted-by":"crossref","unstructured":"Jarlier V, Nicolas MH, Fournier G et al. Extended broad-spectrum \u03b2-lactamases conferring transferable resistance to newer \u03b2-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis1988; 10: 867\u201378.","DOI":"10.1093\/clinids\/10.4.867"},{"key":"key\n\t\t\t\t20171012171720_B23","doi-asserted-by":"crossref","unstructured":"Carter MW, Oakton KJ, Warner M et al. Detection of extended-spectrum \u03b2-lactamases in klebsiellae with the Oxoid combination disk method. J Clin Microbiol2000; 38: 4228\u201332.","DOI":"10.1128\/JCM.38.11.4228-4232.2000"},{"key":"key\n\t\t\t\t20171012171720_B24","doi-asserted-by":"crossref","unstructured":"M'Zali FH, Chanawong A, Kerr KG et al. Detection of extended-spectrum \u03b2-lactamases in members of the family Enterobacteriaceae: comparison of the MAST DD test, the double disc and the Etest ESBL. J Antimicrob Chemother2000; 45: 881\u20135.","DOI":"10.1093\/jac\/45.6.881"},{"key":"key\n\t\t\t\t20171012171720_B25","doi-asserted-by":"crossref","unstructured":"Cormican MG, Marshall SA & Jones RN. Detection of extended-spectrum \u03b2-lactamase (ESBL)-producing strains by the Etest ESBL screen. J Clin Microbiol1996; 34: 1880\u20134.","DOI":"10.1128\/JCM.34.8.1880-1884.1996"},{"key":"key\n\t\t\t\t20171012171720_B26","doi-asserted-by":"crossref","unstructured":"Du B, Long Y, Liu H et al. Extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med2002; 28: 1718\u201323.","DOI":"10.1007\/s00134-002-1521-1"},{"key":"key\n\t\t\t\t20171012171720_B27","doi-asserted-by":"crossref","unstructured":"Lautenbach E, Patel JB, Bilker WB et al. Extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis2001; 32: 1162\u201371.","DOI":"10.1086\/319757"},{"key":"key\n\t\t\t\t20171012171720_B28","doi-asserted-by":"crossref","unstructured":"Paterson DL, Ko WC, Von Gottberg A et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum \u03b2-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol2001; 39: 2206\u201312.","DOI":"10.1128\/JCM.39.6.2206-2212.2001"},{"key":"key\n\t\t\t\t20171012171720_B29","doi-asserted-by":"crossref","unstructured":"Kim YK, Pai H, Lee HJ et al. Bloodstream infections by extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother2002; 46: 1481\u201391.","DOI":"10.1128\/AAC.46.5.1481-1491.2002"},{"key":"key\n\t\t\t\t20171012171720_B30","doi-asserted-by":"crossref","unstructured":"Rice LB, Yao JD, Klimm K et al. Efficacy of different \u03b2-lactams against an extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model. Antimicrob Agents Chemother1991; 35: 1243\u20134.","DOI":"10.1128\/AAC.35.6.1243"},{"key":"key\n\t\t\t\t20171012171720_B31","doi-asserted-by":"crossref","unstructured":"Szabo D, Mathe A, Filetoth Z et al. In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae strain. Antimicrob Agents Chemother2001; 45: 1287\u201391.","DOI":"10.1128\/AAC.45.4.1287-1291.2001"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/56\/3\/451\/2029932\/dki239.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T05:57:39Z","timestamp":1586325459000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/56\/3\/451\/690935\/CTXM-changing-the-face-of-ESBLs-in-the-UK"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,8]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,7,8]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki239","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,9]]},"published":{"date-parts":[[2005,7,8]]}}}